The Role of Centaurin-α1 in Alzheimer’s Disease Pathology
Principal Investigator
Ryohei Yasuda, PhD
Max Planck Florida Institute for Neuroscience
Jupiter, FL, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$250,000
Active Dates
July 01, 2015 - June 30, 2018
Grant ID
A2015251S
Summary
It is thought that Alzheimer’s disease is caused by accumulation of ß-Amyloid. We recently identified that a signaling protein called centaurin-a1 (CentA1) causes ß-Amyloid-induced dysfunction of neurons and thus potentially contributes to brain dysfunction in Alzheimer’s disease. In this project, we will further study the potential roles of CentA1 in Alzheimer’s disease using newly developed CentA1 knockout mice in combination with the model mice for Alzheimer’s disease. We hope that this will lead to new therapeutics targeting CentA1.
Related Grants
Alzheimer's Disease Research
Neuroimaging and Neuropathology of Alzheimer’s Disease in Down Syndrome
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Jr-Jiun Liou, PhD
Current Organization
University of Pittsburgh
Neuroimaging and Neuropathology of Alzheimer’s Disease in Down Syndrome
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Jr-Jiun Liou, PhD
Current Organization
University of Pittsburgh
Alzheimer's Disease Research
Personalized Proteomics to Understand and Predict Alzheimer’s Progression
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Federica Anastasi, PhD
Current Organization
Barcelonaβeta Brain Research Center
Personalized Proteomics to Understand and Predict Alzheimer’s Progression
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Federica Anastasi, PhD
Current Organization
Barcelonaβeta Brain Research Center
Alzheimer's Disease Research
Neurostimulation to Improve Depression and Memory in Dementia
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Davide Cappon, PhD
Current Organization
Hebrew Rehabilitation Center
Neurostimulation to Improve Depression and Memory in Dementia
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Davide Cappon, PhD
Current Organization
Hebrew Rehabilitation Center